Black Stone Minerals, L.P. (BSM) to pay $0.31 on Feb 27, 2018; Durect (DRRX)’s Sentiment Is 2.05

February 15, 2018 - By Marie Mckinney

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and drug delivery programs. The company has market cap of $155.97 million. The firm offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for use as raw materials for pharmaceutical and medical devices under the LACTEL brand. It currently has negative earnings. The Company’s product pipeline consists of multiple investigational drug candidates in clinical development, such as DUR-928, an endogenous, orally bioavailable small molecule that is in Phase 1 development stage to play a regulatory role in lipid homeostasis, inflammation, and cell survival.

Black Stone Minerals, L.P. (NYSE:BSM) is expected to pay $0.31 on Feb 27, 2018. $1.25 is the ADY. (NYSE:BSM) shareholders before Feb 16, 2018 will receive the $0.31 dividend. Black Stone Minerals, L.P.’s current price of $17.78 translates into 1.76% yield. Black Stone Minerals, L.P.’s dividend has Feb 20, 2018 as record date. Feb 9, 2018 is the announcement. The stock increased 2.42% or $0.42 during the last trading session, reaching $17.78. About 189,300 shares traded or 12.23% up from the average. Black Stone Minerals, L.P. (NYSE:BSM) has risen 8.03% since February 15, 2017 and is uptrending. It has underperformed by 8.67% the S&P500.

Gagnon Securities Llc holds 0.79% of its portfolio in DURECT Corporation for 1.25 million shares. Ingalls & Snyder Llc owns 6.43 million shares or 0.59% of their US portfolio. Moreover, Ironwood Investment Management Llc has 0.55% invested in the company for 445,653 shares. The New York-based Mangrove Partners has invested 0.39% in the stock. Kings Point Capital Management, a New York-based fund reported 655,000 shares.

Analysts await DURECT Corporation (NASDAQ:DRRX) to report earnings on March, 13. They expect $-0.05 earnings per share, up 16.67% or $0.01 from last year’s $-0.06 per share. After $0.04 actual earnings per share reported by DURECT Corporation for the previous quarter, Wall Street now forecasts -225.00% negative EPS growth.

The stock decreased 4.55% or $0.05 during the last trading session, reaching $1.05. About 520,111 shares traded. DURECT Corporation (DRRX) has risen 7.89% since February 15, 2017 and is uptrending. It has underperformed by 8.81% the S&P500.

Black Stone Minerals, L.P. owns oil and natural gas mineral interests in the United States. The company has market cap of $3.53 billion. The firm owns mineral interests in approximately 15.5 million acres, nonparticipating royalty interests in 1.5 million acres, and overriding royalty interests in 1.5 million acres located in 41 states and in 64 onshore basins in the continental United States. It has a 27.1 P/E ratio. As of December 31, 2016, the firm had a total estimated proved oil and natural gas reserves of 63,425 thousand barrels of oil equivalent.

Among 8 analysts covering Black Stone Minerals (NYSE:BSM), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Black Stone Minerals has $20 highest and $16 lowest target. $18.25’s average target is 2.64% above currents $17.78 stock price. Black Stone Minerals had 16 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, September 21. The stock of Black Stone Minerals, L.P. (NYSE:BSM) has “Overweight” rating given on Friday, September 25 by Simmons & Co. Stifel Nicolaus maintained it with “Hold” rating and $19 target in Wednesday, January 17 report. PiperJaffray maintained Black Stone Minerals, L.P. (NYSE:BSM) rating on Monday, September 18. PiperJaffray has “Overweight” rating and $19 target. The firm earned “Outperform” rating on Wednesday, March 23 by FBR Capital. The stock of Black Stone Minerals, L.P. (NYSE:BSM) earned “Overweight” rating by Barclays Capital on Wednesday, September 30. Stifel Nicolaus maintained it with “Buy” rating and $18.0 target in Tuesday, August 15 report. On Friday, March 24 the stock rating was upgraded by Stifel Nicolaus to “Buy”. The company was maintained on Tuesday, August 16 by Barclays Capital. Stifel Nicolaus maintained the shares of BSM in report on Wednesday, November 9 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: